Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Tenet Healthcare Corporation (NYSE: THC) brings together the company’s official regulatory disclosures, offering a structured view of how this diversified healthcare services organization reports its activities in the general medical and surgical hospitals industry. As a Nevada-incorporated public company with common stock and certain senior notes listed on the New York Stock Exchange, Tenet files a range of documents with the U.S. Securities and Exchange Commission.
Key filings include Form 8-K current reports that describe material events such as quarterly earnings releases, new credit agreements, amendments to letter of credit facilities, and issuances of senior secured first lien notes and senior notes. These filings explain how Tenet structures its debt, the terms of its revolving credit facility and borrowing base, and the use of proceeds from note offerings to redeem or partially redeem existing notes. 8-K reports also cover governance matters like director resignations and adjustments to board size.
Investors can also use this page to access periodic reports such as annual and quarterly filings when available, which provide segment information for the Ambulatory business (United Surgical Partners International) and the Hospital Operations and Services segment, as well as details on Conifer Health Solutions’ revenue cycle and value-based care services. These documents help clarify how Tenet’s hospital, ambulatory and services operations are reflected in its financial statements and risk disclosures.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, such as new debt issuances, covenant terms, or changes in financial outlook. Real-time updates from EDGAR, combined with simplified explanations of complex credit agreements and note indentures, allow users to quickly understand how new filings may relate to Tenet’s capital structure, liquidity, and operational focus.
Tenet Healthcare EVP & CFO Sun Park reported the vesting and exercise of 3,800 restricted stock units into 3,800 shares of common stock on February 24, 2026, at a price of $0.00 per share. Following these conversions, Park directly holds 18,379 shares of common stock and 7,602 restricted stock units. The RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vesting in three equal annual installments, with the first one-third vesting on February 24, 2026.
Tenet Healthcare CEO Saumya Sutaria reported an increase in directly owned shares through the vesting of restricted stock units. On February 24, 2026, 18,242 "2025 Restricted Stock Units" were exercised or converted, consistent with their one-for-one conversion into common stock.
The transaction delivered 18,242 shares of common stock at a stated price of $0.00 per share, reflecting settlement of time-based awards rather than an open-market purchase. Following these events, Sutaria directly owned 36,486 restricted stock units and 638,923 shares of common stock, all held as direct ownership.
Footnotes explain that the RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vest in three equal annual installments, and are settled in common stock upon vesting. The reported transaction reflects the first one-third of that grant vesting on February 24, 2026.
Tenet Healthcare executive Paola M. Arbour, EVP and Chief Information Officer, reported the vesting and conversion of equity awards tied to her compensation. On February 24, 2026, 1,267 restricted stock units from her 2025 grant converted into an equal number of shares of Tenet common stock at no exercise price.
The restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments, with this filing covering the first one-third tranche. After these transactions, Arbour directly holds 2,534 restricted stock units and 40,271 shares of common stock, reflecting a routine employee equity vesting rather than an open-market purchase or sale.
Tenet Healthcare executive Lisa Y. Foo reported the vesting and conversion of restricted stock units into common shares. On February 24, 2026, 3,800 of her 2025 Restricted Stock Units converted into 3,800 shares of Tenet Healthcare common stock at no exercise price, reflecting an exercise or conversion of a derivative security.
These restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in equal one-third installments on each of the first three anniversaries of the grant date. The first one-third installment vested on February 24, 2026. Following this transaction, she directly holds 53,017 shares of common stock and 7,602 restricted stock units.
TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity. On February 24, 2026, 3,800 of his 2025 Restricted Stock Units were exercised and converted into 3,800 shares of common stock at a stated price of $0.00 per share.
The units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments; the first one-third vested on February 24, 2026. After these transactions, he directly holds 7,602 restricted stock units and 41,585 shares of common stock.
Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units. On February 24, 2026, 443 restricted stock units converted into 443 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Scott directly owned 9,891 shares of common stock and 888 restricted stock units. The units were granted under the 2019 Stock Incentive Plan, vesting in three equal annual installments, with the first third vesting on February 24, 2026 and settled in common stock.
Tenet Healthcare director Nadja West reported a charitable stock gift. On the reported date, she transferred 1,515 shares of Tenet Healthcare common stock as a bona fide gift to a charitable donor-advised fund, with no sale proceeds received. After this donation, she directly owned 26,965 shares.
Tenet Healthcare EVP and COO Lisa Y. Foo acquired 28,339 shares of common stock through a grant of performance-based restricted stock on February 13, 2026. The award was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025.
The shares were granted at no cash cost, with a reported price of $0.0000 per share, and increased her directly held common stock to 49,217 shares after the transaction.
TENET HEALTHCARE CORP executive Paola M. Arbour, EVP and Chief Information Officer, reported acquiring 18,894 shares of common stock through a grant or award on February 13, 2026. The shares were issued at a stated price of $0.0000 per share, bringing her directly held total to 39,004 shares.
According to the disclosure, this grant represents performance-based restricted stock that was earned when the company’s Human Resources Committee certified that applicable performance targets were achieved for the performance period from January 1, 2023 to December 31, 2025.
Tenet Healthcare CEO Saumya Sutaria reported an equity award under the company’s incentive plan. He acquired 245,592 shares of common stock at no cost through a grant of performance-based restricted stock that was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025. Following this award, his directly held common stock position increased to 620,681 shares.